{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:38:42Z","timestamp":1791416322855,"version":"4.3.3"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Mood disorders are highly prevalent among patients with coronary artery disease; however, pharmacologic treatment with selective serotonin reuptake inhibitors (SSRIs) poses potential bleeding concerns, particularly in patients receiving dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). Despite biologic plausibility and observational evidence linking SSRIs to impaired platelet aggregation, data specific to PCI populations remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Using the TriNetX Global Collaborative Network, we identified adults (\u226518 years) who underwent PCI with 12 months of DAPT (aspirin plus a P2Y12 inhibitor) between January 2013 and August 2024. Patients were subdivided into SSRI users and non-users. SSRI users were those who had a prescription record within 12 months prior to PCI and refilled records in both the 0- to 6-month and 6- to 12-month periods following index PCI. SSRI non-users were those who had no SSRI prescriptions within 12 months before and after index PCI. Individuals on anticoagulants, serotonin\u2013norepinephrine reuptake inhibitors, or with recent major bleeding were excluded. Propensity-score matching (1:1) was used to balance baseline characteristics between SSRI users and non-users, and time-to-event outcomes were assessed using Kaplan\u2013Meier and Cox proportional-hazards analyses. The primary endpoint was any major bleeding (intracranial haemorrhage [ICH], gastrointestinal bleeding [GIB], requirement for blood transfusion, or other major bleeding) over 1 year; secondary outcomes included ICH, GIB, transfusion, acute myocardial infarction, stroke\/TIA, and all-cause mortality Of 29 973 PCI patients on DAPT, 3847 used SSRIs. After matching, 3023 SSRI users were compared with 3023 non-users. Over 1 year, major bleeding occurred in 14.0% of SSRI users vs. 11.3% of non-users (HR 1.28; 95% CI 1.11\u20131.48; P &amp;lt; 0.001). SSRI use was associated with a significantly higher risk of ICH (1.2% vs. 0.7%; HR 1.73; 95% CI 1.01\u20132.97; P = 0.043) and GIB (7.4% vs. 5.6%; HR 1.34; 95% CI 1.10\u20131.63; P = 0.004). Red blood cell transfusion (4.6% vs. 4.1%; HR 1.15; 95% CI 0.90\u20131.46; P = 0.267), all-cause mortality (4.1% vs. 3.8%; HR 1.08; 95% CI 0.83\u20131.39; P = 0.573), and ischaemic outcomes were comparable between groups. The association was strongest in patients aged \u226565 years, with hypertension, chronic kidney disease, or concomitant NSAID use and was consistent across ACS and non-ACS presentations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this large, retrospective, real-world cohort, concomitant SSRI therapy during DAPT was associated with an increased bleeding risk, primarily driven by intracranial and gastrointestinal events, without a corresponding increase in ischaemic outcomes, highlighting the importance of clinical awareness of this pharmacodynamic interaction, particularly in higher-risk subgroups, and underscoring the value of established bleeding prevention strategies in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvag034","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:07:47Z","timestamp":1778760467000},"page":"331-342","source":"Crossref","is-referenced-by-count":3,"title":["Selective serotonin reuptake inhibitors and bleeding risk in patients undergoing PCI on dual antiplatelet therapy: a retrospective cohort study"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7029-2369","authenticated-orcid":false,"given":"Ishmum","family":"Chowdhury","sequence":"first","affiliation":[{"name":"Jacobi Medical Center, Albert Einstein College of Medicine , Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0763-8157","authenticated-orcid":false,"given":"Kuan-Yu","family":"Chi","sequence":"additional","affiliation":[{"name":"Jacobi Medical Center, Albert Einstein College of Medicine , Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9618-3267","authenticated-orcid":false,"given":"Yu","family":"Chang","sequence":"additional","affiliation":[{"name":"Section of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital , Tainan 704 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3252-6719","authenticated-orcid":false,"given":"Pei-Lun","family":"Lee","sequence":"additional","affiliation":[{"name":"Jacobi Medical Center, Albert Einstein College of Medicine , Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Torrado","sequence":"additional","affiliation":[{"name":"Montefiore Medical Center, Albert Einstein College of Medicine , Bronx, NY 10467 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Aaysha","family":"Cader","sequence":"additional","affiliation":[{"name":"Kettering General Hospital NHS Foundation Trust , Kettering NN16 8UZ ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Mangalesh","sequence":"additional","affiliation":[{"name":"Jacobi Medical Center, Albert Einstein College of Medicine , Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyansh","family":"Shah","sequence":"additional","affiliation":[{"name":"Jacobi Medical Center, Albert Einstein College of Medicine , Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adir","family":"Alper","sequence":"additional","affiliation":[{"name":"Jacobi Medical Center, Albert Einstein College of Medicine , Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidubem","family":"Ezenna","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Massachusetts-Baystate Medical Center , Springfield, MA 01199 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Nouri","sequence":"additional","affiliation":[{"name":"Section of Cardiovascular Medicine, Yale School of Medicine , New Haven, CT 06510 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiza","family":"Rossi","sequence":"additional","affiliation":[{"name":"Section of Cardiovascular Medicine, Yale School of Medicine , New Haven, CT 06510 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafer","family":"Akman","sequence":"additional","affiliation":[{"name":"Section of Cardiovascular Medicine, Yale School of Medicine , New Haven, CT 06510 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla A","family":"Damluji","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Cardiovascular Center on Aging, the Cleveland Clinic Foundation , Cleveland, OH 44195 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Nanna","sequence":"additional","affiliation":[{"name":"Section of Cardiovascular Medicine, Yale School of Medicine , New Haven, CT 06510 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"2026071411422015600_pvag034-B1","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3390\/JCM14061786","article-title":"Prevalence of depression, anxiety and post-traumatic stress disorder (PTSD) after acute myocardial infarction: a systematic review and meta-analysis","volume":"14","author":"Chong","year":"2025","journal-title":"J Clin Med"},{"key":"2026071411422015600_pvag034-B2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/J.JACC.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026071411422015600_pvag034-B3","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1093\/EURHEARTJ\/EHAF191","article-title":"2025 ESC clinical consensus statement on mental health and cardiovascular disease: developed under the auspices of the ESC clinical practice guidelines committee: developed by the task force on mental health and cardiovascular disease of the European Society of Cardiology (ESC)Endorsed by the European federation of psychologists\u2019 associations AISBL (EFPA), the European psychiatric association (EPA), and the international society of behavioral medicine (ISBM)","volume":"46","author":"Bueno","year":"2025","journal-title":"Eur Heart J"},{"key":"2026071411422015600_pvag034-B4","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/CIR.0B013E3182949A2E","article-title":"Cardiovascular health: the importance of measuring patient-reported health status a scientific statement from the American Heart Association","volume":"127","author":"Rumsfeld","year":"2013","journal-title":"Circulation"},{"key":"2026071411422015600_pvag034-B5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.5694\/MJA13.10153","article-title":"Screening, referral and treatment for depression in patients with coronary heart disease","volume":"198","author":"Colquhoun","year":"2013","journal-title":"Med J Aust"},{"key":"2026071411422015600_pvag034-B6","first-page":"online","article-title":"Depression following acute coronary syndrome events: screening and treatment guidelines from the AAFP","volume":"99","author":"Frost","year":"2019","journal-title":"Am Fam Physician"},{"key":"2026071411422015600_pvag034-B7","first-page":"313","volume-title":"Ischemic Stroke Therapeutics: A Comprehensive Guide","author":"Belagaje","year":"2023"},{"key":"2026071411422015600_pvag034-B8","doi-asserted-by":"publisher","first-page":"e243208","DOI":"10.1001\/JAMANETWORKOPEN.2024.3208","article-title":"Concomitant use of selective serotonin reuptake inhibitors with oral anticoagulants and risk of major bleeding","volume":"7","author":"Rahman","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026071411422015600_pvag034-B9","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/S10620-022-07788-Y","article-title":"Risk of gastrointestinal bleeding with concurrent use of NSAID and SSRI: a systematic review and network meta-analysis","volume":"68","author":"Haghbin","year":"2023","journal-title":"Dig Dis Sci"},{"key":"2026071411422015600_pvag034-B10","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1503\/CMAJ.100912\/-\/DC1","article-title":"Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction","volume":"183","author":"Labos","year":"2011","journal-title":"CMAJ"},{"key":"2026071411422015600_pvag034-B11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0165-0327(92)90082-H","article-title":"Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement","volume":"25","author":"Celada","year":"1992","journal-title":"J Affect Disord"},{"key":"2026071411422015600_pvag034-B12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1042\/CS0910087","article-title":"Platelet 5-hydroxytryptamine is decreased in a preliminary group of depressed patients receiving the 5-hydroxytryptamine re-uptake inhibiting drug fluoxetine","volume":"91","author":"Menys","year":"1996","journal-title":"Clin Sci (Lond)"},{"key":"2026071411422015600_pvag034-B13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1067\/MCP.2000.110456","article-title":"Paroxetine decreases platelet serotonin storage and platelet function in human beings","volume":"68","author":"Hergovich","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"2026071411422015600_pvag034-B14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/J.PHRS.2016.08.017","article-title":"Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies","volume":"118","author":"Laporte","year":"2017","journal-title":"Pharmacol Res"},{"key":"2026071411422015600_pvag034-B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.24875\/RECICE.M22000268","article-title":"Selective serotonin reuptake inhibitors and bleeding risk after PCI. A propensity score matching study","volume":"4","author":"Gonz\u00e1lez-Manzanares","year":"2022","journal-title":"REC: Interventional Cardiology"},{"key":"2026071411422015600_pvag034-B16","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0019819","article-title":"Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study","volume":"6","author":"Carvajal","year":"2011","journal-title":"PLoS One"},{"key":"2026071411422015600_pvag034-B17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008755","article-title":"Selective serotonin reuptake inhibitors and bleeding risk in anticoagulated patients with atrial fibrillation: an analysis from the ROCKET AF trial","volume":"7","author":"Quinn","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026071411422015600_pvag034-B18","doi-asserted-by":"publisher","DOI":"10.1093\/JAMIAOPEN\/OOAD035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"2026071411422015600_pvag034-B19","doi-asserted-by":"publisher","DOI":"10.1016\/J.JBI.2021.103847","article-title":"Assessing real-world medication data completeness","volume":"119","author":"Evans","year":"2021","journal-title":"J Biomed Inform"},{"key":"2026071411422015600_pvag034-B20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/JAMA.2022.0210","article-title":"Comparison of mRNA-1273 and BNT162b2 vaccines on breakthrough SARS-CoV-2 infections, hospitalizations, and death during the delta-predominant period","volume":"327","author":"Wang","year":"2022","journal-title":"JAMA"},{"key":"2026071411422015600_pvag034-B21","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1038\/S41467-024-50199-Y","article-title":"GLP-1 receptor agonists\u2019 impact on cardio-renal outcomes and mortality in T2D with acute kidney disease","volume":"15","author":"Pan","year":"2024","journal-title":"Nat Commun"},{"key":"2026071411422015600_pvag034-B22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41746-021-00467-8","article-title":"A vital sign-based prediction algorithm for differentiating COVID-19 versus seasonal influenza in hospitalized patients","volume":"4","author":"Yanamala","year":"2021","journal-title":"NPJ Digit Med"},{"key":"2026071411422015600_pvag034-B23","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S1470-2045(24)00278-X","article-title":"Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study","volume":"25","author":"Wan","year":"2024","journal-title":"Lancet Oncol"},{"key":"2026071411422015600_pvag034-B24","doi-asserted-by":"publisher","first-page":"e2517541","DOI":"10.1001\/JAMANETWORKOPEN.2025.17541","article-title":"GLP-1 RA use and major adverse cardiovascular events in patients with monoclonal gammopathy of undetermined significance","volume":"8","author":"Chi","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026071411422015600_pvag034-B25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/J.JCHF.2025.01.025","article-title":"Sodium-glucose cotransporter 2 inhibitors in tafamidis-treated transthyretin amyloid cardiomyopathy: a contemporary real-world analysis","volume":"13","author":"Chi","year":"2025","journal-title":"JACC Heart Fail"},{"key":"2026071411422015600_pvag034-B26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/EHJQCCO\/QCAF104","article-title":"Global uptake of GLP-1 receptor agonists in obese, non-diabetic patients with cardiovascular disease","volume":"12","author":"Chi","year":"2026","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026071411422015600_pvag034-B27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2026071411422015600_pvag034-B28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"Van Der Weele","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026071411422015600_pvag034-B29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/EURHEARTJ\/EHX419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European association for cardio-thoracic surgery (EACTS)","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"2026071411422015600_pvag034-B30","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMOA0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"2026071411422015600_pvag034-B31","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/J.JCIN.2016.04.009","article-title":"Time-dependent associations between actionable bleeding, coronary thrombotic events, and mortality following percutaneous coronary intervention: results from the PARIS registry","volume":"9","author":"Baber","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2026071411422015600_pvag034-B32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/J.TRSL.2007.10.004","article-title":"Selective serotonin reuptake inhibitors (SSRIs): measurement of effect on platelet function","volume":"151","author":"McCloskey","year":"2008","journal-title":"Transl Res"},{"key":"2026071411422015600_pvag034-B33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2165\/00129784-200303030-00001","article-title":"Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction?","volume":"3","author":"Schlienger","year":"2003","journal-title":"Am J Cardiovasc Drugs"},{"key":"2026071411422015600_pvag034-B34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/J.IJCARD.2006.03.038","article-title":"Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications","volume":"116","author":"Parissis","year":"2007","journal-title":"Int J Cardiol"},{"key":"2026071411422015600_pvag034-B35","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2165\/11589340-000000000-00000","article-title":"Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients","volume":"28","author":"De Abajo","year":"2011","journal-title":"Drugs Aging"},{"key":"2026071411422015600_pvag034-B36","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/J.EURPSY.2004.09.018","article-title":"Bleeding induced by SSRIs","volume":"20","author":"Ceylan","year":"2005","journal-title":"Eur Psychiatry"},{"key":"2026071411422015600_pvag034-B37","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/BCP.70432","article-title":"Risk of gastrointestinal bleeding by specific SSRIs and SNRIs: a systematic review and meta-analysis","volume":"92","author":"Gomez-Lumbreras","year":"2026","journal-title":"Br J Clin Pharmacol"},{"key":"2026071411422015600_pvag034-B38","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/S11748-020-01353-Y","article-title":"Use of serotonin reuptake inhibitors is not associated with increased bleeding after CABG","volume":"68","author":"Heimisdottir","year":"2020","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2026071411422015600_pvag034-B39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/0267659118765933","article-title":"Do selective serotonin reuptake inhibitors increase the risk of bleeding or mortality following coronary artery bypass graft surgery? A meta-analysis of observational studies","volume":"33","author":"Eckersley","year":"2018","journal-title":"Perfusion"},{"key":"2026071411422015600_pvag034-B40","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1681\/ASN.2020101440\/-\/DCSUPPLEMENTAL","article-title":"Platelet function in CKD: a systematic review and meta-analysis","volume":"32","author":"Baaten","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026071411422015600_pvag034-B41","doi-asserted-by":"publisher","first-page":"968","DOI":"10.18553\/JMCP.2017.23.9.968","article-title":"Major bleeding risk during anticoagulation with warfarin, dabigatran, apixaban, or rivaroxaban in patients with nonvalvular atrial fibrillation","volume":"23","author":"Adeboyeje","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"2026071411422015600_pvag034-B42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/S40140-021-00498-7\/TABLES\/2","article-title":"Coagulation and aging: implications for the anesthesiologist","volume":"11","author":"Tschan","year":"2021","journal-title":"Curr Anesthesiol Rep"},{"key":"2026071411422015600_pvag034-B43","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1093\/EURHEARTJ\/EHI480","article-title":"Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT","volume":"26","author":"Van Melle","year":"2005","journal-title":"Eur Heart J"},{"key":"2026071411422015600_pvag034-B44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/J.BIOPSYCH.2006.09.029","article-title":"Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes","volume":"62","author":"Frasure-Smith","year":"2007","journal-title":"Biol Psychiatry"},{"key":"2026071411422015600_pvag034-B45","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1161\/HC4201.097834","article-title":"Depression, heart rate variability, and acute myocardial infarction","volume":"104","author":"Carney","year":"2001","journal-title":"Circulation"},{"key":"2026071411422015600_pvag034-B46","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.CIR.0000085163.21752.0A","article-title":"Platelet\/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the sertraline AntiDepressant heart attack randomized trial (SADHART) platelet substudy","volume":"108","author":"Serebruany","year":"2003","journal-title":"Circulation"},{"key":"2026071411422015600_pvag034-B47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/J.JPSYCHORES.2008.03.012","article-title":"Depression is associated with flatter cortisol rhythms in patients with coronary artery disease","volume":"65","author":"Bhattacharyya","year":"2008","journal-title":"J Psychosom Res"},{"key":"2026071411422015600_pvag034-B48","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1249\/01.MSS.0000125997.63493.13","article-title":"Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial","volume":"36","author":"Blumenthal","year":"2004","journal-title":"Med Sci Sports Exerc"},{"key":"2026071411422015600_pvag034-B49","doi-asserted-by":"publisher","first-page":"e008530","DOI":"10.1161\/CIRCINTERVENTIONS.119.008530","article-title":"Clinical usefulness of PRECISE-DAPT score for predicting bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an analysis from the SMART-DATE randomized trial","volume":"13","author":"Choi","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2026071411422015600_pvag034-B50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4244\/EIJ-D-20-00052","article-title":"Validation of the academic research consortium for high bleeding risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores","volume":"16","author":"Ueki","year":"2020","journal-title":"EuroIntervention"},{"key":"2026071411422015600_pvag034-B51","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.108.190769","article-title":"Depression and coronary heart disease: recommendations for screening, referral, and treatment\u2014a science advisory from the American Heart Association prevention committee of the council on cardiovascular nursing, council on clinical cardiology, council on epidemiology and prevention, and interdisciplinary council on quality of care and outcomes research","volume":"118","author":"Lichtman","year":"2008","journal-title":"Circulation"},{"key":"2026071411422015600_pvag034-B52","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/EURHEARTJ\/EHAD191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2026071411422015600_pvag034-B53","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/EURHEARTJ\/EHAE177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) endorsed by the European association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvag034\/68290919\/pvag034.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/4\/331\/68290919\/pvag034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/4\/331\/68290919\/pvag034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:42:28Z","timestamp":1784043748000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/12\/4\/331\/8678730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5,15]]},"published-print":{"date-parts":[[2026,7,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvag034","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,5,15]]}}}